Article Details

EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments

Retrieved on: 2024-06-21 22:47:30

Tags for this article:

Click the tags to see associated articles and topics

EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments. View article details on hiswai:

Excerpt

EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments. Pharmaceutical Technology· Shutterstock/Hadayeva Sviatlana.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo